Article

Motivational, proteostatic and transcriptional deficits precede synapse loss, gliosis and…

medRxiv · 2016 · Bragg, R. M.; Coffey, S. R.; Weston, R. M.; Ament, S. A.; Cantle, J. P.; Minnig, S.; Funk, C. C.; Shuttleworth, D. D.; Woods, E. L.; Sullivan, B. R.; Jones, L.; Glickenhaus, A.; Anderson, J. S.; Anderson, M. D.; Dunnett, S. B.; Wheeler, V. C.; MacDonald, M. E.; Brooks, S. P.; Price, N. D.; Carroll, J. B.

Key facts

Title Motivational, proteostatic and transcriptional deficits precede synapse loss, gliosis and neurodegeneration in the B6.HttQ111/+ model of Huntington’s disease
First author Bragg, R. M.; Coffey, S. R.; Weston, R. M.; Ament, S. A.; Cantle, J. P.; Minnig, S.; Funk, C. C.; Shuttleworth, D. D.; Woods, E. L.; Sullivan, B. R.; Jones, L.; Glickenhaus, A.; Anderson, J. S.; Anderson, M. D.; Dunnett, S. B.; Wheeler, V. C.; MacDonald, M. E.; Brooks, S. P.; Price, N. D.; Carroll, J. B.
Journal medRxiv
Published Oct 14, 2016
DOI 10.1101/081109
Devices mentioned BK110039, K834056, K862384, K862385, K922230, K922885, K925155
Product codes mentioned DZM, EBF, EID, EIE, ELW, GDJ, JJH, KIF, KJJ, KLE, LRO, LRW and 6 more

At a glance

  • 1–9 FDA submissions mentioned
  • 10–99 Product codes mentioned

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About Literature

Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.

Source: Publisher and PubMed metadata; device mentions identified by Orca1

Browse all Literature